Page 78 - Read Online

Fraser. J Transl Genet Genom 2018;2:21. I https://doi.org/10.20517/jtgg.2018.27 Page 15 of 15

78. Løvf M, Zhao S, Axcrona U, Johannessen B, Bakken AC, et al. Multifocal primary prostate cancer exhibits high degree of genomic hetero-
geneity. Eur Urol 2018; doi: 10.1016/j.eururo.2018.08.009.
79. Wedge DC, Gundem G, Mitchell T, Woodcock DJ, Martincorena I, et al. Sequencing of prostate cancers identifies new cancer genes, routes
of progression and drug targets. Nat Genet 2018;50:682-92.
80. Wang X, Qiao Y, Asangani IA, Ateeq B, Poliakov A, et al. Development of peptidomimetic inhibitors of the ERG gene fusion product in
prostate cancer. Cancer Cell 2017;31:532-48.
81. Hamdy FC, Donovan JL, Lane JA, Mason M, Metcalfe C, et al. 10-year outcomes after monitoring, surgery, or radiotherapy for localized
prostate cancer. N Engl J Med 2016;375:1415-24.
82. Albertsen PC, Hanley JA, Fine J. 20-year outcomes following conservative management of clinically localized prostate cancer. JAMA
2005;293:2095-101.
83. Ross-Adams H, Lamb AD, Dunning MJ, Halim S, Lindberg J, et al. Integration of copy number and transcriptomics provides risk stratifica-
tion in prostate cancer: a discovery and validation cohort study. EBioMedicine 2015;2:1133-44.
84. Su F, Zhang W, Zhang D, Zhang Y, Pang C, et al. Spatial intratumor genomic heterogeneity within localized prostate cancer revealed by
single-nucleus sequencing. Eur Urol 2018;74:551-9.
85. Kim Y, Ignatchenko V, Yao CQ, Kalatskaya I, Nyalwidhe JO, et al. Identification of differentially expressed proteins in direct expressed
prostatic secretions of men with organ-confined versus extracapsular prostate cancer. Mol Cell Proteomics 2012;11:1870-84.
86. Viswanathan SR, Ha G, Hoff AM, Wala JA, Carrot-Zhang J, et al. Structural alterations driving castration-resistant prostate cancer revealed
by linked-read genome sequencing. Cell 2018;174:433-47.
87. Taylor BS, Schultz N, Hieronymus H, Gopalan A, Xiao Y, et al. Integrative genomic profiling of human prostate cancer. Cancer Cell
2010;18:11-22.
88. Camacho N, Van Loo P, Edwards S, Kay JD Matthews L, et al. Appraising the relevance of DNA copy number loss and gain in prostate
cancer using whole genome DNA sequence data. PLoS Genet 2017;13:e1007001.
89. Ren S, Wei GH, Liu D, Wang L, Hou Y, et al. Whole-genome and transcriptome sequencing of prostate cancer identify new genetic altera-
tions driving disease progression. Eur Urol 2017; doi: 10.1016/j.eururo.2017.08.027.